BioFire seeks FDA clearance for blood culture ID system

04/17/2013 | GenomeWeb Daily News (free registration)

BioFire Diagnostics has filed a 510(k) clearance application with the FDA for a device that can screen positive blood cultures simultaneously for about 90% of the yeast microbes and gram-positive or gram-negative bacteria tied to bloodstream infections. The FilmArray Blood Culture Identification, or BCID, system could be released in the summer if cleared by the FDA.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel, Regulatory (FDA)
CareFusion
San Diego , CA
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations